Corient Private Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
1,031
-513
| -33% | -$124K | ﹤0.01% | 2193 |
|
|
2025
Q1 | $376K | Sell |
1,544
-667
| -30% | -$162K | ﹤0.01% | 1735 |
|
|
2024
Q4 | $726K | Sell |
2,211
-452
| -17% | -$148K | ﹤0.01% | 1448 |
|
|
2024
Q3 | $891K | Buy |
2,663
+91
| +4% | +$30.4K | ﹤0.01% | 1428 |
|
|
2024
Q2 | $702K | Buy |
2,572
+356
| +16% | +$97.2K | ﹤0.01% | 1465 |
|
|
2024
Q1 | $766K | Buy |
2,216
+38
| +2% | +$13.1K | ﹤0.01% | 1422 |
|
|
2023
Q4 | $703K | Buy |
2,178
+220
| +11% | +$71K | ﹤0.01% | 1435 |
|
|
2023
Q3 | $702K | Sell |
1,958
-1,140
| -37% | -$409K | ﹤0.01% | 1315 |
|
|
2023
Q2 | $1.17M | Sell |
3,098
-667
| -18% | -$253K | ﹤0.01% | 1091 |
|
|
2023
Q1 | $1.81M | Buy |
3,765
+609
| +19% | +$292K | ﹤0.01% | 872 |
|
|
2022
Q4 | $1.33M | Buy |
+3,156
| New | +$1.33M | ﹤0.01% | 824 |
|